Core Viewpoint - *ST Haihua has appointed Zhongrui Cheng Certified Public Accountants as its auditing firm for the fiscal year 2025, with a high approval rate of 99.2450% at the shareholders' meeting, marking a temporary resolution to the ongoing changes in auditing firms [1][10]. Group 1: Appointment of Auditing Firm - The appointment of Zhongrui Cheng as the auditing firm was approved with 99.2450% of votes in favor, indicating strong shareholder support [1][12]. - This appointment does not eliminate the core audit risks associated with the company's efforts to maintain its listing status, compounded by delayed regulatory inquiries and unverified performance forecasts [12][14]. Group 2: Audit Fee Increases - The audit fees have significantly increased during this transition, with Zhongrui Cheng's fees set at 1.5 million yuan, which is an increase of 87.5% compared to the previous year's fees from the former auditor [5][16]. - The breakdown of the fees shows that the financial audit fee has increased by 118.2%, indicating a focus on verifying the authenticity and compliance of revenue [16]. Group 3: Financial Performance and Regulatory Scrutiny - The company forecasts a revenue of 336 million yuan for 2025, just above the delisting threshold of 300 million yuan, with growth attributed to two acquisitions [5][16]. - Regulatory bodies have mandated monthly disclosures regarding the gas business's performance and have raised concerns about the revenue recognition practices of a newly established subsidiary [6][16]. Group 4: Audit Challenges Ahead - Despite the approval of the new auditing firm, uncertainties remain regarding the company's ability to meet the delisting criteria, as the new auditor has not yet commenced formal audits [7][17]. - The upcoming audit will be challenging due to the complexity of the company's finances and the need to provide thorough verification of revenue, especially given the limited experience of the new auditing firm in handling securities audits [17][18].

Group 1 - The core issue is the difficulty faced by certain listed companies in finding new auditing firms, leading to increased delisting risks as the annual report disclosure deadline approaches [1][2][4] - As of February 2, 2026, two companies, *ST Haihua and *ST Sailong, have not secured new auditors after their previous firms resigned, raising concerns about their ability to disclose annual reports on time [2][4] - A total of eight companies have changed auditors since the beginning of 2026, with many of them showing signs of financial distress and having been flagged for potential delisting [1][5] Group 2 - The resignation of auditing firms often reflects their cautious approach towards companies with high audit risks, potentially due to issues like financial fraud or operational difficulties [3][6] - Companies that fail to secure new auditors risk receiving non-standard audit opinions or missing the legal deadline for annual report disclosures, which could lead to delisting [3][4] - The trend of frequent auditor changes during the critical reporting period indicates underlying operational challenges and heightened audit risks for the affected companies [7]

Core Viewpoint - The article discusses the shift in securities regulatory requirements from "formal compliance" to "substantive authenticity" in the context of the registration system reform, questioning whether Zhejiang Hengdao Technology Co., Ltd. has alleviated concerns regarding the authenticity of its revenue in its second-round inquiry response [1][14]. Group 1: Company Overview - Zhejiang Hengdao Technology Co., Ltd. is under review by the Beijing Stock Exchange, with its application accepted on June 13, 2025, and the latest update on January 21, 2026 [2][14]. - The company is sponsored by Guotai Junan Securities Co., Ltd., with representatives Lu Qi and Wu Shaochao, and audited by Tianjian Certified Public Accountants, with signatory accountants Wei Jianqing and Zhou Wangfei [2][14]. Group 2: Audit and Verification Concerns - There are concerns regarding the effectiveness of audit measures for a significant portion of small and micro clients, with 87% of these clients potentially lacking adequate verification [2][14]. - The on-site visit coverage for clients with transactions below 500,000 yuan has been low, with only 21.08% of small clients visited in 2024, indicating over 500 clients have not been verified by intermediaries [5][6][18]. - The audit process has been criticized for its low external confirmation rates, with only 17.62% of small clients receiving confirmation letters in 2024, raising questions about compliance with auditing standards [21][23]. Group 3: Risk of Revenue Inflation - A significant portion of Hengdao Technology's revenue (20%-30%) comes from high-risk clients, defined as those with registered capital below 500,000 yuan or newly established during the reporting period, which raises concerns about potential revenue inflation through shell companies [22][23]. - The identification of 136 clients with discrepancies in confirmation addresses or contacts signals a high level of fraud risk, suggesting that confirmation letters may not have reached the intended recipients [10][25]. Group 4: Ineffective Verification Methods - The reliance on internal documents for verification, such as contracts and orders, without independent third-party evidence, is questioned, as it may lead to circular reasoning in audits [21][26]. - The audit team’s explanations for address discrepancies, such as group procurement or internal personnel handling, are deemed inadequate and raise further doubts about the integrity of the verification process [10][25].

Core Viewpoint - Company *ST Lifan (300344.SZ) has applied for a one-day suspension of trading due to market rumors and is facing significant risks of forced delisting due to major legal violations [1][2] Group 1: Company Suspension and Legal Issues - Company announced a one-day trading suspension starting January 19, 2026, and will resume trading on January 20, 2026, to verify related information [1] - Company received an administrative penalty and market ban notice on November 28, and has applied to the CSRC for a statement, defense, and hearing extension, which is a normal procedure [1] - Company stock faces a significant risk of forced delisting if it receives an administrative penalty decision that triggers delisting conditions [1] Group 2: Financial Performance - For the first nine months of 2025, the company reported revenue of 203.33 million yuan, a year-on-year decrease of 0.44%, and a net loss attributable to shareholders of 62.21 million yuan, a year-on-year decline of 20.59% [1] - Preliminary forecasts indicate that the company's net profit for the entire year of 2025 is expected to remain negative [1] Group 3: Audit and Compliance Risks - The company's internal control for the 2024 financial report received a negative audit opinion from Zhongxing Caiguanghua Accounting Firm, which is currently under investigation [1] - The company has not completed the reappointment of its auditing firm, and the annual audit work has not officially commenced, leading to certain audit risks [1]

Core Viewpoint - *ST Lifan (300344) has announced a one-day suspension of trading to investigate market rumors regarding potential administrative penalties and risks of forced delisting due to significant legal violations [1] Group 1: Market Rumors and Company Actions - The company has noted media reports about a public letter from the actual controller of Lifan Shuke to all shareholders [1] - On November 28, the company and related parties received a notice regarding administrative penalties and market entry bans, which is part of the normal procedure for appealing to the China Securities Regulatory Commission (CSRC) [1] - The company acknowledges the risk of forced delisting if it encounters circumstances that trigger such actions [1] Group 2: Audit and Financial Reporting Risks - The company has not yet completed the appointment of a new auditing firm, which poses certain audit risks [1] - The current auditor, Zhongxing Cai Guanghua Accounting Firm, is under investigation, potentially affecting the ability to conduct the audit for the 2025 annual report [1] - The company will announce the administrative penalty decision promptly once received, and trading is set to resume on January 20, 2026 [1]

Core Viewpoint - Ruikang Pharmaceutical has terminated its cooperation with Zhongxing Caiguanghua Accounting Firm and appointed Shenzhen Jiuan to undertake the 2025 audit, raising concerns about potential audit risks and independence issues [3][4]. Group 1: Company Actions - The company announced the change in auditors on December 24, citing "comprehensive consideration of business development and audit needs" without providing further details [3]. - The decision to change auditors comes just before the annual audit process, which typically starts in January and concludes by the end of April [3]. Group 2: Regulatory Issues - Ruikang Pharmaceutical has faced multiple regulatory warnings over the past five years, including a warning from the Shandong Securities Regulatory Bureau in December 2023 for serious violations [3]. - Specific violations include failing to disclose a 4.6 billion yuan related party transaction and not timely reporting litigation matters totaling 5.84 billion yuan [3]. Group 3: Management Turmoil - In July 2023, the company experienced significant management changes, including the detention of a board member and the resignation of the actual controller's son [4]. - These management upheavals coincide with a decline in the company's operational performance [4]. Group 4: Financial Performance - Revenue for Ruikang Pharmaceutical has seen significant declines from 2020 to 2024, with year-on-year decreases of 22.84%, 22.67%, 41.54%, 34.74%, and a slight drop of 0.85% in 2025 [4]. - The net profit for the company has also deteriorated, with a 63% year-on-year decline in the first three quarters of 2025 [4]. Group 5: Industry Context - Ruikang Pharmaceutical is not alone in terminating its relationship with Zhongxing Caiguanghua; at least 30 other A-share companies have also ended their partnerships with the firm amid concerns over its audit practices [5][6]. - The wave of terminations is linked to Zhongxing Caiguanghua's involvement in a financial fraud case, which has led to regulatory scrutiny and investigations [6].